drugset / Trial / NCT00051025
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to look at the safety and effectiveness of ONTAK in previously treated patients with NHL.
Timeline
- Start
- 2000-05
- Primary completion
- 2001-01
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | denileukin diftitox | Protein / enzyme biologic | — | — |